46 studies found for:    " January 06, 2010":" February 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
2 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
3 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
4 Completed Treatment for Depression Among HIV-Infected Youth
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management;   Behavioral: TAU - Treatment as Usual
5 Withdrawn An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
Conditions: HIV;   HIV Infections
Intervention: Drug: Valacyclovir
6 Active, not recruiting Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
7 Unknown  High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
8 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
9 Completed Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
10 Completed
Has Results
Fosamprenavir in Pts With Hepatic Impairment
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Intervention A Standard dose;   Drug: Intervention B Reduced Dose;   Drug: Intervention C;   Drug: Intervention D;   Drug: Intervention E
11 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
12 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
13 Active, not recruiting Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
14 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:
15 Completed Observational Study of Blood Treated With Cytolin
Condition: HIV Infections
Intervention:
16 Active, not recruiting Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Condition: HIV Infections
Intervention: Drug: ibalizumab
17 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
18 Completed Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Conditions: Healthy;   HIV Infections
Interventions: Drug: Digoxin;   Drug: Maraviroc
19 Completed MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
Conditions: Acne Vulgaris;   Allergic Rhinitis (Disorder);   Anxiety;   Asthma;   Back Pain;   Prostatic Hyperplasia;   Bursitis;   Chronic Obstructive Pulmonary Disease;   Cough;   Coronary Artery Disease;   Depression;   Diabetes Mellitus;   Diarrhea;   Gastroesophageal Reflux;   Fibromyalgia;   Headache;   HIV Infections;   Hypothyroidism;   Hyperlipidemia;   Hypertension;   Influenza;   Sleep Initiation and Maintenance Disorders;   Irritable Bowel Syndrome;   Knee Pain;   Migraine Disorders;   Obesity;   Obstructive Sleep Apnea;   Osteoarthritis;   Senile Osteoporosis;   Colonoscopy;   Mammography;   Shoulder Pain;   Sinusitis;   Smoking Cessation;   Tobacco Use Cessation;   Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaccination;   Vaginitis;   Vertigo
Intervention: Other: health information prescription
20 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years